Timothy Veenstra, Section Editor, Proteomics and metabolomics Integration of an ever-increasing variety and quantity of biological, clinical, epidemiological, environmental, functional, genetic, genomic, pathological and physiological data through systems approaches is the cornerstone for the personalized treatment of individuals, the ultimate goal of doctors since the Greek founders of medicine.
They often include standard features such as age, sex, smoking and family history, but also increasingly include more complex clinical measures such as biomarkers, relating to a diverse range of measurable biological (including genomic), pathological, imaging, clinical, and physiological variables.
Karyotyping is a cytogenetic technique performing a standardized and effective single cell screening in order to identify significant genomic aberrations in pathological and in normal samples.
Together, these functional validation results and correlative analysis of human tissues support the thesis that integrated genomic and pathological analyses of staged melanomas provide a productive entry point for discovery of melanoma metastases genes.
The different genomic profiles are shown in figure 1. Clinical, pathological and genomic data at diagnosis and follow-up events (local and distant recurrences, second cancers, death from uveal melanoma or from any other cause) were prospectively collected.
In both groups, Kaplan-Meier method and log-rank test were adopted to conduct an explorative analysis with the aim of estimating the importance of each clinical, pathological and genomic feature in predicting Hazard Ratios (HR) for progression and death.
Furthermore, combining clinical, radiological, pathological and genomic data in trial populations with innovative trial designs (such as in the MINDACT trial [ 84]) will allow us to relate, compare and combine established markers to, and with, new technologies in a range of settings.
To better characterize thyroid toxicity associated with increased cancer risk in the rat, genomic, clinical, and pathological end points were examined in response to excess NaI (non-carcinogen) and the rodent thyroid carcinogens PB and PTU in a modified 2-week endocrine battery (O'Connor et al. 2002).
This will help improve our understanding of the pathological and physiological roles of ribonucleotides in genomic DNA, of significance to both nucleic acid-driven autoimmunity and carcinogenesis.
